In the News March 1, 2021

The Pink Sheet | Drug Manufacturers Beg US FDA to Inspect Facilities, but Still Find Difficulties

Cathy Burgess is quoted on COVID-19 safety considerations for Food and Drug Administration inspections.
Media Contact
Nicholas Clarke
Communications Director
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.